Media-OutReach Newswire GangaGen Secures additional US$7.9 Million from CARB-X for Pre-clinical Development of Novel Klebicins Targeting Nosocomial Pneumonia caused by Multidrug-resistant Klebsiella pneumoniae
Media-OutReach Newswire Honouring Malaysia’s Rising Influence: ACES Awards 2024 Celebrate Leaders and Companies Shaping a Sustainable Future